From: Prospective, open, multi-centre phase I/II trial to assess safety and efficacy of neoadjuvant radiochemotherapy with docetaxel and oxaliplatin in patients with adenocarcinoma of the oesophagogastric junction
Dose level
Event
1
2
3
Total
Number of patients
3 (100%)
11 (100%)
4 (100%)
18 (100%)
Any event
1 (33%)
2 (18%)
1 (25%)
4 (22%)
Pericardial effusion
1 (6%)
Fever
Infection
1 (9%)
Pleural effusion